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Urinary exosomes have been proposed as starting material
for discovery of protein biomarkers of kidney disease.
Current protocols for their isolation use a two-step
differential centrifugation process. Due to their low density,
exosomes are expected to remain in the low-speed
(17,000 g) supernatant and to sediment only when the
sample is spun at high speed (200,000 g). Analysis using
western blot and electron microscopy found that urinary
exosomes are also present in the low-speed pellet entrapped
by polymeric Tamm-Horsfall protein, thus diminishing the
procedure’s reproducibility. Here we show that addition of
dithiothreitol to the low-speed pellet disrupted the polymeric
network, presumably by reduction of disulfide bonds linking
the monomers. This modification shifted the exosomal
proteins from the low- to the high-speed pellet. Also, by
shifting the Tamm-Horsfall protein to the high-speed pellet,
the use of dithiothreitol makes it feasible to use Tamm-
Horsfall protein to normalize excretion rates of exosomal
proteins in spot urines. We tested this by western blot, and
found that there was a high degree of correlation between
exosomal proteins and Tamm-Horsfall protein in the high-
speed pellet. Since the yield of exosomes by differential
centrifugation can be increased by chemical reduction,
Tamm-Horsfall protein may be a suitable normalizing
variable for urinary exosome studies when quantitative urine
collections are not practical.
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Exosomes are small (20–100 nm) membrane vesicles that
originate as the internal vesicles of multivesicular bodies in
many cell types. They are released from the multivesicular
body lumen into the extracellular environment (including
plasma and urine) on fusion of the outer membrane of the
multivesicular bodies with the plasma membrane. Since the
initial description of exosomes in urine by Pisitkun et al. in
2004,1 there have been several studies focusing on the
physiological and pathophysiological significance of these
vesicles in urine.2–7 Urinary exosomes contain proteins that
are characteristic of every renal tubule epithelial cell type, as
well as podocytes and transitional epithelia from the urinary
collecting system.1 Therefore urinary exosomes provide a
suitable starting material for biomarker discovery relevant to
a variety of disease processes. One barrier to success with this
approach is the presence of large amounts of Tamm-Horsfall
protein (THP) in urine.8
THP, also known as uromodulin, is the most abundant
protein in urine under physiological conditions. It is a
glycosylphosphatidylinositol-linked membrane protein synthe-
sized exclusively in the thick ascending limb of Henle’s loop.
It has a zona pellucida (ZP) domain of approximately 260
amino acids including 8–10 conserved cysteine residues. THP
is targeted to the plasma membrane and is secreted into the
urine through an extracellular proteolytic cleavage, allowing
delivery into the tubule fluid. THP is found in the urine as
a high-molecular-weight polymer assembled into filaments
or matrices. The ZP domain presumably functions as a
polymerization module.9–11 The function of THP has been
investigated but there is no strong consensus regarding its
role in normal kidney physiology.12 A study in THP gene-
deficient mice suggested that THP may regulate the
transporters in Henle’s loop.13
The isolation of urinary exosomes usually shows a two-
step differential centrifugation process.1 In an initial low-
speed spin (17,000 g), high-density membranes and poly-
merized THP are normally removed. Owing to the low
density of the exosomes, they are expected to remain in the
supernatant from this spin. In the second spin at 200,000 g,
urinary exosomes are normally found in the pellet.1 The large
polymeric THP network has the potential to trap exosomes
in the 17,000 g pellet, thus preventing efficient and
reproducible isolation in the subsequent 200,000 g spin.
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In this work we show a substantial quantity of urinary
exosomes precipitates by entrapment by polymeric THP in
the 17,000 g spin. We show that the entrapment can be
eliminated by chemical reduction of disulfide bonds with
dithiothreitol (DTT), thereby depolymerizing the THP. In
addition, we also discuss the lack of a standard method for
normalizing protein measurements in urinary exosomes and
propose the use of THP as a normalizing variable.
RESULTS
THP sedimentation during centrifugation
Figure 1 shows a Coomassie-stained gel of the 17,000 and
200,000 g pellets from pooled normal human urine (three
subjects) with and without addition of the reducing agent
DTT at the time of 17,000 g centrifugation. The large band
centered at about 92 kDa is known to represent THP
monomer.8 As can be seen, a substantial amount of THP
was present in the 17,000 g pellet without reduction and
most of it was moved to the 200,000 g fraction when the
sample was reduced (Figure 1).
Electron microscopy
To explain the findings in Figure 1, we carried out electron
microscopy of the 17,000 g pellets prepared from one
subject (Figure 2) either without (panels a and b) or with
(panel c) DTT treatment. As shown in Figure 2a and b, the
THP formed long polymeric filaments that associated
laterally to form ropelike structures. The complex THP
network was seen to contain small (20–100 nm) vesicles
compatible with exosomes (Figure 2b). When treated with
DTT, the THP meshwork was dissipated (Figure 2c). Figure
2d shows a few short convoluted THP oligomers present in
the 200,000 g pellet incubated with DTT at the time of the
17,000 g centrifugation.
To investigate the apparent entrapment of exosomes in
more detail, we processed pooled urine (three subjects) with
and without DTT and then carried out immunoblotting of
the 17,000 and 200,000 g fractions for two exosomal
markers, Alix and TSG101, as well as two integral membrane
proteins normally present in urinary exosomes, CD9 and
aquaporin-2 (AQP2)1 (Figure 3). Because cooling is known
to increase THP polymerization and because urine samples
are normally stored either at 4 or 80 1C, we compared the
same urine samples processed fresh (Figure 3a), stored at 4 1C
for 3 days before processing (Figure 3b), and stored at 80 1C
for 3 days before processing (Figure 3c). The signals for Alix,
TSG101, and AQP2 in the 17,000 g pellets were diminished
by DTT reduction regardless of storage, whereas CD9 was not
seen in the 17,000 g pellet even without DTT. This finding
is consistent with the conclusion above that there is
significant entrapment of exosomes by the unreduced THP
polymeric network. The absence of CD9 in the unreduced
17,000 g fraction may suggest that some subpopulations of
exosome-like vesicles escape entrapment.
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Figure 1 | Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS—PAGE) of 17,000 and 200,000 g
pellets treated with and without dithiothreitol (DTT) and
stained with Coomassie blue. Tamm-Horsfall protein (THP) is
seen as a broad band around 92 kDa. The addition of DTT, a
reducing agent, shifted the sedimentation of THP mainly from the
low-speed pellet to the high-speed pellet. The procedure applied
in this experiment involved incubation of the 17,000 g pellet
with DTT and a second 17,000 g centrifugation after
resuspension. The same percentages of the 17,000 and
200,000 g pellet’s final volume were loaded on the gel.
800 nm
800 nm
100 nm100 nm
Figure 2 | Electron microscope images of the 17,000g
pellets without (a and b) and with (c) dithiothreitol (DTT)
treatment and the 200,000g pellet with DTT treatment (d).
Tamm-Horsfall protein (THP) formed long polymeric filaments
that associated laterally to form ropelike structures (a, original
magnification:  5000 and b, depicting the dashed box in a with
magnification  40,000). The THP network contained small
(20–100 nm) vesicles compatible with exosomes (b, arrowheads).
Treatment with DTT disrupted the THP meshwork (c, original
magnification:  5000), leaving short convoluted THP oligomers
(d, original magnification:  40,000).
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In additional experiments, the 17,000 g pellet was
incubated with different DTT concentrations (50, 100, and
200 mg/ml), temperatures (37, 45, 50, 60, and 95 1C), and
incubation times (2, 5, 10, and 15 min) (Supplementary
Figures). The best enrichment of urinary exosome markers,
without any protein aggregation or degradation, was
observed with 200 mg/ml of DTT at 37 1C for 5–10 min. In
each case, the DTT was added to the 17,000 g pellet, the
pellet was resuspended, incubated, and recentrifuged.
We have repeated the isolation of urinary exosomes with
and without DTT five times, collecting urine from different
normal subjects each time. We have observed the following:
(1) the size of the 17,000 g pellets is variable between
different experiments, (2) the addition of DTT to the low-
speed centrifugation pellet shifts the majority of THP from
the low-speed pellet to the high-speed pellet, (3) exosomal
markers are generally not detected in the low-speed pellet
when it is incubated with DTT, and (4) urinary exosomal
enrichment is variable between the different experiments but
the highest signal in the 200,000 g pellet is always realized
when the 17,000 g pellets are reduced with DTT.
Urinary exosome-like particle counting by electron
microscopy
To assess the yield of exosome-like particles with the
DTT-reduction protocol, we counted vesicles using electron
micrographs of the 200,000 g pellets from six normal
human subjects. The same fraction of the pellet was placed
on electron microscopic grids and 20 electron micrographic
fields were counted at  20,000 magnification from each
subject (see Supplementary Table 1 for the raw vesicle
counting data). A sampling error of ±9% was estimated for
this procedure (Supplementary Table 1). Urinary ‘exosome-
like particles’ were defined on the basis of the size
(20–100 nm) and the shape (round) of the vesicles (Figure 4).
Note that the DTT treatment has no obvious effect on
morphology of the exosome-like particles. The minimal rate
of excretion of these particles was calculated from the data
giving a value of 4440±1639 (s.d.) particles per min.
Because, we do not know the efficiency of binding of the
particles to the electron microscopy grids in these determina-
tions, we consider this a ‘minimum’ value.
Relation between exosome-like particle counts and exosomal
marker proteins
To determine whether the exosome marker protein abun-
dance correlates with the counts of exosome-like particles, we
carried out immunoblotting in the 200,000 g fraction of the
same samples used for the exosome counting described in the
previous paragraph (n¼ 6) (Figure 5a), comparing the
exosomal proteins Alix, CD9, TSG101, HSP70, and AQP2.
These immunoblots were loaded with an amount of
each sample calculated to give an equal number of
exosome-like particles based on the quantitative electron
microscopy described above. As can be seen, the band
intensity values of all markers were highly variable among the
normal human subjects. The most likely explanation for this
is that the exosome-like particles varied from sample to
sample in composition or ability to bind to the electron
microscopy grid.
Normalization with THP
We asked whether THP may provide a reliable normalization
variable to allow quantitative analysis in untimed collections
of urine (‘spot’ urine samples). To address this question, we
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Figure 3 | Immunoblots of the 17,000 and the 200,000g
pellets with and without dithiothreitol (DTT) treatment
probed against exosomal proteins Alix, TSG101, CD9, and
AQP2. The same urine samples were processed fresh (a), stored at
4 1C for 3 days before processing (b), and stored at 80 1C for
3 days before processing (c).
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also carried out immunoblotting for THP in the same
samples described in the last section (Figure 5a, bottom
immunoblot). This allowed us to plot the signal from each
exosomal protein against the THP signal from immunoblot-
ting (Figure 5b). The correlation coefficients for each protein
are also summarized in Figure 5b. As seen, the correlation
was high with correlation coefficients ranging from 0.84 to
0.99. The highest correlation coefficients were for Alix and
TSG101, which are components of the protein complexes
that form pro-exosomes in multivesicular bodies. Thus, THP
amount is representative of the amount of exosomal markers
and can potentially be substituted as a normalizing variable
in spot urines. This is significant because it obviates the need
for immunoblotting of exosomal markers for normalization,
as the amount of THP from immunoblots and the amount of
THP deduced from densitometry of Coomassie-stained gels
correlate very highly (Figure 6). Consequently, normalization
can potentially be carried out on the basis of measurements
of THP in Coomassie-stained gels.
100 nm 100 nm 20 nm
Figure 4 | Electron microscope images of the dithiothreitol (DTT)-treated 200,000g pellets from normal human subjects at
 20,000 magnification. This magnification was used to identify exosome-like particles based on the size (20–100 nm) and the shape
(round) of the vesicles (arrowheads). Figures a–c represent fields from different subjects.
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Figure 5 | Immunoblotting of 200,000g pellets from six
normal human subjects probed against exosomal proteins
Alix, CD9, TSG101, HSP70, and AQP2 as well as Tamm-Horsfall
protein (THP). (a) These immunoblots were loaded based on an
equal number of exosome-like particles. (b) Scatter plot relating
the band intensities of the exosomal proteins and THP.
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Figure 6 |Correlation of Tamm-Horsfall protein (THP) band
intensities from Coomassie-stained gels and THP
immunoblots of 200,000g urine pellets. A correlation
between the amounts of THP deduced from densitometry of
Coomassie-stained gels and THP immunoblots was very high
(r¼ 0.99, linear regression analysis).
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DISCUSSION
The objective of this study was to solve the problem of
inconsistent isolation of urinary exosomes. We proposed that
exosomes were being variably entrapped by polymeric
networks of Tamm-Horsfall protein and showed such
entrapment by electron microscopy. Our experiments showed
that dissolution of the THP polymeric network through the
use of the reducing agent DTT markedly reduced the amount
of exosomal marker proteins (TSG101 and Alix) in the low-
speed fraction from centrifugation of urine samples. There-
fore, the exosomes were more completely retrieved in the
subsequent high-speed fraction. We recommend therefore
that the standard protocol for exosome isolation by
differential centrifugation be modified to use DTT treatment
of the resuspended low-speed pellet with a repeat of the low-
speed (17,000 g) spin. Figure 7 represents our current
protocol based on the findings of this study. In addition we
include a written protocol in the Supplementary Materials.
Tamm-Horsfall protein is related to the ZP family of
proteins. ZP proteins form a polymeric meshwork that
creates a barrier around a fertilized egg to prevent
polyspermy. The polymerization is through disulfide linkages
between ZP protein monomers resulting in a linear polymer.
The pattern of distribution of cysteines in THP proteins is
similar to that seen in ZP proteins. The success of DTT
treatment in disrupting THP polymerization strongly sup-
ports the notion that disulfide linkages are also responsible
for THP polymerization. THP was found to form ropelike
structures by lateral aggregation of the THP monomeric
chains (Figure 2). The physical basis for the lateral
association is presently unknown.
In addition, we looked in additional detail about urine
storage for exosome isolation. Our previous study concluded
that freezing samples at 20 1C markedly reduced the
retrieval of exosomes from urine samples14 but did not
explain the loss. Here we compared storage at 4 and 80 1C
with the yield using fresh urine samples. The immunoblot-
ting did not show a substantial loss of exosomal marker
proteins at either temperature. However, there was a small
amount of retention of exosomal marker proteins in the
17,000 g pellet even with DTT, suggesting that the
mechanism of this small retention may depend on a process
other than entrapment by THP networks (Figure 3). Thus,
analysis of fresh samples seems to be superior. However,
freezing at 80 1C appears to be a reasonable choice if long-
term storage is necessary. Other than the temperature, the
ionic strength and pH of urine can also contribute to THP
aggregation.15 However, this study did not investigate the role
of these factors on THP aggregation and exosome isolation.
Thus, future studies are needed to address this issue
experimentally.
Biomarker discovery and exploitation depend on devel-
opment of methods for quantifying urinary excretion rates of
proteins. However, the timed collections needed for the
calculation of such rates are not always practical in a clinic
setting. Thus, a normalization variable is needed to substitute
for time in calculations of relative excretion rate of exosomal
proteins. (Because water excretion is highly variable,
comparison of absolute protein concentrations in urine is
never a reasonable alternative.) One alternative for a
normalizing variable would be exosomal markers such as
Alix or TSG101. Such measurements, however, add to the
complexity of the overall determination. Here we show that
the level of THP in the 200,000 g pellet correlates very
highly with the levels of Alix or TSG101 (Figure 5). Hence,
THP may be a suitable normalizing variable, especially as its
level is easily assessed by densitometry of Coomassie-stained
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS—PAGE) and does not require an immunoassay. THP is
secreted by the thick ascending limb of Henle’s loop and,
Collect urine at room temperature
Current procedure for urinary exosome isolation
Centrifuge at 17,000 ×g, 37 °C, 10 min
Keep supernatant (SN1)
Resuspend pellet in isolation solution
Add isolation solution and centrifuge at 17,000 ×g, 37 °C, 10 min
Keep supernatant (SN2)
Pool SN1 and SN2
Discard supernatant
Pellet contains exosomes
THP polymer
THP oligomers
Exosome-like particle
Cellular debris, high-density vesicles
Ultracentrifuge supernatants at 200,000 ×g, 37 °C, 1 h
Add DTT (200 mg/ml). Heat at 37 °C for 5–10 min
Add protease inhibitors
Figure 7 |Current procedure for urinary exosome isolation.
The new procedure adds the step of dithiothreitol (DTT)
incubation of the 17,000 g pellet to depolymerize the
Tamm-Horsfall protein (THP) polymeric network, followed by a
second 17,000 g spin to recover the exosomes that were
entrapped by the THP network. The two 17,000 g supernatants
are pooled.
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although its secretion is unlikely to be invariant among
subjects, it is more likely to be relatively constant in the same
subject. The advantage of THP over measurement of
creatinine or some other substance filtered at the glomerulus
is that it can be measured in the same high-speed differential
centrifugation fraction that is used to assay potential
biomarkers. Hence, factors that would cause THP to vary
either physiologically or technically (in the isolation process)
would be common to THP determination and the determi-
nation of any other protein in that fraction. Thus, we would
expect that THP normalization would give a smaller
systematic error than normalization by creatinine. In this
study, we investigated the potential use of THP as a
normalizing variable for estimation of relative excretion rates
of exosomal proteins only in normal human subjects. Further
studies are required to address the validity of THP as a
normalizing variable in subjects with renal disease.
MATERIALS AND METHODS
Urine collection
Urine was collected from 10 male healthy subjects (ages 22–43;
NIDDK Clinical Research Protocol no. 00-DK-0107). Twelve-hour
collections were used for the exosome counting by electron
microscopy and in normalization experiments. The first morning
void urine was used for the remainder of the experiments. The urine
sample was collected in a sterile container added with a protease
inhibitor mixture (volume per 50 ml of urine: 1.67 ml of 100 mM
NaN3, 2.5 ml of 10 mM AEBSF, and 50 ml of 2 mM leupeptin). For the
first morning void urine collection, 50 ml of urine was collected and
the protease inhibitor mixture was added immediately after
collection. For the 12-h urine collection, 59 ml of the protease
inhibitor mixture was added to a container before collection (based
on the assumption that a normal human produces 600–800 ml of
urine in 12 h). Except where explicitly noted, urine was processed
immediately after collecting without storage.
Isolation of urinary exosomes by ultracentrifugation
Urine (96 ml) was used for centrifugation. Urine samples were
placed in a centrifuge (Beckman L8-70M ultracentrifuge; Beckman
Coulter, Fullerton, CA) and centrifuged at 17,000 g for 10 min at
37 1C (13,600 r.p.m.). The supernatant was saved and the 17,000 g
pellets were resuspended in an isolation solution (250 mM sucrose,
10 mM triethanolamine (pH 7.6)) followed by incubation with either
DTT (final concentration of 200 mg/ml; MP Biomedicals, Solon,
OH) or vehicle at 37 1C for 5–10 min. During the DTT or vehicle
incubation, samples were vortexed every 2 min. The temperature,
incubation time, and DTT concentration were chosen on the basis
of preliminary experiments (see Supplementary Figures). The
incubated suspensions were then transferred to clean centrifuge
tubes (Beckman polycarbonate catalog no. 355630) and more
isolation solution was added to a final volume of 8 ml. The
samples were centrifuged again at 17,000 g for 10 min at 37 1C.
The two supernatants from the 17,000 g spins were pooled and
ultracentrifuged at 200,000 g for 1 h at 37 1C. Pellets were
solubilized in 1.5% SDS and 50 mM Tris-HCl (pH 6.8). These
samples were used for immunoblotting as described below. For the
electron microcopy of urinary exosomes, pellets obtained from the
200,000 g spin from each subject were resuspended in 1
phosphate-buffered saline.
Electron microcopy of urinary exosomes
Vesicle suspensions for electron microscopy were further diluted 1:10
with phosphate-buffered saline and 5ml suspension was applied to
glow-discharged formvar-carbon films on copper 300 mesh grids
(catalog no. 71150; Electron Microscopy Sciences, Hatfield, PA). The
adsorbed exosomes were negatively stained with 1% aqueous uranyl
acetate. The samples were examined with a JEM 1200EX electron
microscope (JEOL, Peabody, MA, USA) equipped with an AMT XR60B
digital camera (Advanced Microscopy Techniques, Danvers, MA, USA).
Exosome counting
Exosomes from six normal subjects were used for this procedure.
Five fields located in the center, upper right and left, and lower right
and left of the grid were selected for viewing the exosomes from each
subject. Four electron micrographs in each selected field were
randomly taken at  20,000 magnification. Under this magnifica-
tion the exosomes were clearly identifiable by their size, between 20
and 100 nm, and their round shape.1 In brief, 20 electron
micrographs were taken for each subject, therefore a total of 120
electron micrographs were taken for the entire procedure. The rate
of excretion of ‘exosome-like particles’ was calculated based on the
collection times for each sample, the dilution volumes at various
stages of the procedure, and the areas of the electron microscopy
field counted.
Immunoblotting and antibodies
Immunoblotting was carried out as described previously.1 Briefly,
urinary exosome pellets were solubilized in Laemmli sample
buffer (1.5% SDS, 6% glycerol, and 10 mM Tris-HCl (pH 6.8)).
Gel loading of urinary exosome was based on the same percentage
of the pellet’s final volume or on the estimated number of exosome-
like vesicles counted as described previously. Proteins were separated
by one-dimensional SDS–PAGE and were transferred to nitrocellu-
lose membranes, which were blocked and probed with antigen-
specific primary antibodies. The blots were incubated with species-
specific fluorescent secondary antibodies (Alexa 688) and were
visualized using the Odyssey Infrared Imaging System (Li-Cor,
Lincoln, NE).
Antibodies acquired from commercial suppliers were TSG101
(ab83; Abcam, Cambridge, MA), Alix (AIP1; BD Biosciences,
San Jose, CA, USA), CD9 (C-4; Santa Cruz Biotechnology,
Santa Cruz, CA, USA), HSP 70 (StressMarq, Victoria, Canada),
Tamm-Horsfall protein (H-135; Santa Cruz Biotechnology). We also
used a rabbit antibody to AQP2 produced in our laboratory.16
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SUPPLEMENTARY MATERIAL
Table S1. Exosome counting.
Figure S1. Coomassie blue-stained SDS–PAGE gels of 17,000 g
pellets before and after the treatments with different concentrations
of DTT for 5min at 37 1C.
Figure S2. Aquaporin-2 (AQP2) immunoblots of 17,000 and
200,000 g pellets after incubation of the 17,000 g pellets with 200
mg/ml DTT at different temperatures and incubation times.
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Figure S3. Alix and aquaporin-2 immunoblots of 17,000 and
200,000 g pellets after incubation of the 17,000 g pellets with
200mg/ml DTT at 37 1C for 5, 10, or 15 min.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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